HEADER DE NOVO PROTEIN/ HYDROLASE 25-NOV-05 2F50 TITLE THEORETICAL MODEL OF AN EVMBL8 COMPLEXED WITH THE CEFOTAXIME COMPND MOL_ID: 1; COMPND 2 MOLECULE: METALLO BETA-LACTAMASE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: EVMBL8; COMPND 5 EC: 3.5.2.6 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN KEYWDS METALLO BETA-LACTAMASE, EVMBL8-CEFOTAXIME COMPLEX EXPDTA THEORETICAL MODEL AUTHOR J.K.LEE,T.MOON,H.-S.PARK,H.-S.KIM,C.N.YOON REVDAT 2 02-MAY-06 2F50 1 AUTHOR REVDAT 1 28-FEB-06 2F50 0 JRNL AUTH H.-S.PARK,S.-H.NAM,J.K.LEE,C.N.YOON,B.MANNERVIK, JRNL AUTH 2 S.J.BENKOVIC,H.-S.KIM JRNL TITL DESIGN AND EVOLUTION OF NEW CATALYTIC ACTIVITY JRNL TITL 2 WITH AN EXISTING PROTEIN SCAFFOLD. JRNL REF SCIENCE V. 311 535 2006 JRNL REFN ASTM SCIEAS US ISSN 0036-8075 REMARK 1 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : NANOMODEL REMARK 3 AUTHORS : JONES,ZOU,COWAN,KJELDGAARD REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: MODEL OF EVMBL8 WAS CONSTRUCTED REMARK 3 USING CCRA (PDB ENTRY: 1A7T) AS TEMPLATE THAT WAS SELECTED REMARK 3 FROM A PROFILE-BASED SEARCH USING SEQUENCE HOMOLOGY. THE REMARK 3 COMPARATIVE MODELING WAS PERFORMED USING PROTEIN STRUCTURE REMARK 3 MODELING PROGRAM, NANOMODEL (NANORMICS INC.). REMARK 4 REMARK 4 2F50 COMPLIES WITH FORMAT V. 2.3, 09-JULY-1998 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 24-JAN-2006. REMARK 100 THE RCSB ID CODE IS RCSB035460. REMARK 220 REMARK 220 EXPERIMENTAL DETAILS REMARK 220 EXPERIMENT TYPE : THEORETICAL MODELLING REMARK 220 REMARK 220 REMARK: NULL REMARK 225 REMARK 225 THEORETICAL MODEL REMARK 225 THE COORDINATES IN THIS ENTRY REPRESENT A MODEL STRUCTURE. REMARK 225 PROTEIN DATA BANK CONVENTIONS REQUIRE THAT CRYST1 AND REMARK 225 SCALE RECORDS BE INCLUDED, BUT THE VALUES ON THESE REMARK 225 RECORDS ARE MEANINGLESS. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 THR A 197 REMARK 465 ILE A 198 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES: ENGH AND HUBER, 1991 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 HIS A 149 ND1 - CE1 - NE2 ANGL. DEV. = 11.8 DEGREES REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 149 -67.55 111.44 REMARK 500 ALA A 161 -94.35 179.30 REMARK 999 REMARK 999 THERE IS NO AMINOACID SEQUENCE DATABASE REFERENCE AVAILABLE REMARK 999 FOR THE PROTEIN DBREF 2F50 A 23 198 UNP Q16775 GLO2_HUMAN 15 177 SEQRES 1 A 198 MET LYS VAL GLU VAL LEU PRO ALA LEU THR THR VAL ALA SEQRES 2 A 198 GLY TRP GLY GLU VAL PRO SER ASN GLY TYR LEU VAL ILE SEQRES 3 A 198 ASP ASP GLY THR LYS GLU ALA ALA ILE VAL ASP THR PRO SEQRES 4 A 198 PHE THR ALA ILE ASP THR GLU LYS LEU ALA ASP ALA ALA SEQRES 5 A 198 GLY LYS HIS GLY VAL GLU PRO THR THR VAL SER ALA THR SEQRES 6 A 198 HIS TRP HIS TRP ASP CYS ASP GLY GLY ASN GLU GLU LEU SEQRES 7 A 198 VAL LYS LEU GLU SER GLY PRO GLU VAL TYR GLY GLY ASP SEQRES 8 A 198 GLY ARG ILE ASN LEU ALA LYS GLU LYS TRP LEU ARG ALA SEQRES 9 A 198 LEU ALA HIS LYS ILE ALA HIS LEU SER THR LEU LEU VAL SEQRES 10 A 198 GLU SER LEU SER VAL LYS CYS PRO TYR PRO GLY PRO GLY SEQRES 11 A 198 HIS SER THR ASP ASP ILE CYS TYR PHE ALA SER LYS PRO SEQRES 12 A 198 GLY GLY PRO GLU PRO HIS PRO VAL PHE ARG GLY CYS PHE SEQRES 13 A 198 ILE LYS PRO CYS ALA LEU PRO GLU VAL LEU ASP PRO THR SEQRES 14 A 198 ALA ASP GLU MET ALA LYS ALA LEU LEU GLU VAL LEU GLY SEQRES 15 A 198 ARG LEU PRO LEU ASP THR ARG VAL TYR TYR GLY HIS GLU SEQRES 16 A 198 TYR THR ILE HET ZN 251 1 HET ZN 252 1 HET CE3 255 46 HETNAM ZN ZINC ION HETNAM CE3 (6S,7S)-3-[(ACETYLOXY)METHYL]-7-{[(2E)-2-(2-AMINO-1,3- HETNAM 2 CE3 THIAZOL-4-YL)-2-(METHOXYIMINO)ETHANOYL]AMINO}-8-OXO-5- HETNAM 3 CE3 THIA-1-AZABICYCLO[4.2.0]OCT-2-ENE-2-CARBOXYLIC ACID HETSYN CE3 CEFOTAXIME FORMUL 2 ZN 2(ZN 2+) FORMUL 4 CE3 C16 H17 N5 O7 S2 FORMUL 5 HOH *2(H2 O1) HELIX 1 1 THR A 41 GLY A 56 1 16 HELIX 2 2 HIS A 68 GLY A 73 1 6 HELIX 3 3 GLY A 74 LEU A 78 5 5 HELIX 4 4 ASP A 91 LYS A 100 1 10 HELIX 5 5 THR A 169 LEU A 184 1 16 SHEET 1 A 6 VAL A 3 VAL A 5 0 SHEET 2 A 6 TYR A 23 VAL A 25 -1 O LEU A 24 N GLU A 4 SHEET 3 A 6 ALA A 33 VAL A 36 -1 O ALA A 34 N VAL A 25 SHEET 4 A 6 PRO A 59 SER A 63 1 O THR A 61 N ILE A 35 SHEET 5 A 6 GLU A 86 GLY A 90 1 O TYR A 88 N VAL A 62 SHEET 6 A 6 HIS A 107 ILE A 109 1 O HIS A 107 N VAL A 87 SHEET 1 B 2 THR A 11 VAL A 12 0 SHEET 2 B 2 GLY A 16 GLU A 17 -1 O GLY A 16 N VAL A 12 SHEET 1 C 2 THR A 114 VAL A 117 0 SHEET 2 C 2 LEU A 120 LYS A 123 -1 O LEU A 120 N VAL A 117 SHEET 1 D 2 VAL A 151 GLY A 154 0 SHEET 2 D 2 VAL A 190 TYR A 192 1 O TYR A 191 N VAL A 151 CISPEP 1 GLY A 29 THR A 30 0 3.09 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MASTER 71 0 3 5 12 0 0 6 0 0 0 16 END